Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1)
Nathan A. Brooks(Eli Lilly (United States)), Raymond Gilmour(Eli Lilly (Spain)), Lisa Kays(Eli Lilly (United States)), Zoran Ranković(St. Jude Children's Research Hospital), Sandra María Gómez(Eli Lilly (United States)), Gary Mo(University of Illinois Chicago), John Strelow(Eli Lilly (United States)), Stephen Antonysamy(Eli Lilly (United States)), Robin DeWalt(Eli Lilly (United States)), Denis McCann(Eli Lilly (United States)), Rachel N. Cavitt(Eli Lilly (United States)), Paul Milligan(MRC Unit the Gambia), Kenneth Roth(Eli Lilly (United States)), Serge L. Boulet(Eli Lilly (United States)), Sandaruwan Geeganage(Eli Lilly (United States)), Patric J. Hahn(Eli Lilly (United States)), Ramón V. Tiu(Eli Lilly (United States)), Renato A. Bauer(Eli Lilly (United States)), Timothy P. Burkholder(Eli Lilly (United States)), ZhaoHai Lu(Eli Lilly (United States))
Cited by 0
Related Papers
Bulletin of the World Health Organization
|Bulletin of the World Health Organization|2001|7.2k
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study
|The Lancet|2005|288
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
|Nature Medicine|2004|266
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190